NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Allogene Therapeutics (ALLO)

Technical Analysis Report for NASDAQ stock ALLO Allogene Therapeutics. Dated: 02 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALLO Allogene Therapeutics then click here. or read Experts views on Allogene Therapeutics or Forecast & share price targets of Allogene Therapeutics

Allogene Therapeutics Opened at 2.16 and Closed at: 2.05, which is -5.37% of previous session's close. It moved within a range of 2.04 and 2.16
The session was a Bearish session with an average volume of 7373700, which is -5.98% of previous session's volumes.

Support for tomorrow is 1.99 and resistance for tomorrow is 2.11
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.01, 1.96 resistance for tomorrow's hourly charts is 2.13, 2.2

10 Day SMA for Allogene Therapeutics (ALLO) is 2.08 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Allogene Therapeutics (ALLO) is 2.15 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Allogene Therapeutics (ALLO) is 2.3 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.16 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Allogene Therapeutics is 1.72 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Allogene Therapeutics is at 2.15 and 200 DMA is at 1.72, while 50 DMA and 100 DMA are at 2.3 and 2.16 respectively

Allogene Therapeutics (ALLO) moving average of 20 SMA is at 2.15 and 20 EMA is at 2.15

Allogene Therapeutics (ALLO) moving average of 50 SMA is at 2.3 and 50 EMA is at 2.2

Allogene Therapeutics (ALLO) moving average of 100 SMA is at 2.16 and 100 EMA is at 2.08

Allogene Therapeutics (ALLO) moving average of 200 SMA is at 1.72 and 200 EMA is at 1.91

Allogene Therapeutics has performed better than Xencor Inc in short term. Holding Allogene Therapeutics could be a better choice for now!

Allogene Therapeutics has performed better than Sarepta Therapeutics in short term. Holding Allogene Therapeutics could be a better choice for now!

Replimune Group has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Replimune Group, about 170.91% more returns!

Quidel Corporation has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Quidel Corporation, about 32.52% more returns!

Puma Biotechnology has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Puma Biotechnology, about 4.95% more returns!

Opko Health has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Opko Health, about 36.26% more returns!

Alnylam Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 5.69% more returns!

Allogene Therapeutics has performed better than Benitec Biopharma in short term. Holding Allogene Therapeutics could be a better choice for now!

Allogene Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Allogene Therapeutics could be a better choice for now!

Cumberland Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 43.3% more returns!

Allogene Therapeutics has performed better than Corbus Pharmaceuticals in short term. Holding Allogene Therapeutics could be a better choice for now!

Denali Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Denali Therapeutics, about 6.07% more returns!

Ensign Group has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Ensign Group, about 5.45% more returns!

Grifols S has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Grifols S, about 1.99% more returns!

Allogene Therapeutics has performed better than Heron Therapeutics in short term. Holding Allogene Therapeutics could be a better choice for now!

Irhythm Technologies has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Irhythm Technologies, about 0.89% more returns!

Allogene Therapeutics Technical analysis of indicators

Price action analysis of Allogene Therapeutics (ALLO) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Allogene Therapeutics in short term but the buy signal is initial and weak.

Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Allogene Therapeutics in short term but SELL signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Allogene Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.1 and Allogene Therapeutics ALLO stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Allogene Therapeutics ALLO stock. Volume based technical analysis of Allogene Therapeutics ALLO stock is negative.

Allogene Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ALLO Allogene Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ALLO Experts View which covers a lot of information including buying and selling signals

ALLO future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Allogene Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet